Nordhealth AS
OSE:NORDH.OL
23.4 (NOK) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) NOK.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2020 Q4 | 2020 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 12.205 | 10.147 | 10.129 | 8.838 | 9.188 | 8.671 | 8.458 | 8.027 | 7.509 | 7.056 | 6.403 | 5.768 | 4.785 | 3.853 | 3.064 |
| Cost of Revenue
| 1.785 | 1.411 | 1.39 | 1.274 | 1.314 | 1.193 | 1.297 | 1.215 | 1.175 | 1.093 | 1.314 | 0.922 | 0.918 | 0.418 | 0.45 |
| Gross Profit
| 10.42 | 8.736 | 8.739 | 7.564 | 7.874 | 7.478 | 7.161 | 6.812 | 6.334 | 5.963 | 5.089 | 4.846 | 3.867 | 3.435 | 2.614 |
| Gross Profit Ratio
| 0.854 | 0.861 | 0.863 | 0.856 | 0.857 | 0.862 | 0.847 | 0.849 | 0.844 | 0.845 | 0.795 | 0.84 | 0.808 | 0.892 | 0.853 |
| Reseach & Development Expenses
| 1.967 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0.879 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0.879 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses
| 3.039 | 0 | 0 | 0 | 0 | 10.786 | 11.162 | 10.425 | 10.433 | 8.929 | 7.09 | 5.663 | 5.993 | 2.652 | 2.03 |
| Operating Expenses
| 11.972 | 11.424 | 12.263 | 9.527 | 10.465 | 10.786 | 11.162 | 10.425 | 10.433 | 8.929 | 7.09 | 5.663 | 5.993 | 2.652 | 2.03 |
| Operating Income
| -1.551 | -2.688 | -3.534 | -1.954 | -2.592 | -3.308 | -4.001 | -3.613 | -4.099 | -2.966 | -2.665 | -0.351 | -2.087 | 0.785 | 0.589 |
| Operating Income Ratio
| -0.127 | -0.265 | -0.349 | -0.221 | -0.282 | -0.382 | -0.473 | -0.45 | -0.546 | -0.42 | -0.416 | -0.061 | -0.436 | 0.204 | 0.192 |
| Total Other Income Expenses Net
| -0.052 | 0.34 | 0.226 | 0.122 | 0.253 | -0.019 | -0.384 | 0.238 | 0.647 | 0.05 | 0.643 | -0.225 | -0.313 | 0.038 | -0.016 |
| Income Before Tax
| -1.603 | -2.348 | -3.308 | -1.832 | -2.339 | -3.327 | -4.385 | -3.375 | -3.452 | -2.916 | -2.022 | -0.576 | -2.4 | 0.823 | 0.573 |
| Income Before Tax Ratio
| -0.131 | -0.231 | -0.327 | -0.207 | -0.255 | -0.384 | -0.518 | -0.42 | -0.46 | -0.413 | -0.316 | -0.1 | -0.502 | 0.214 | 0.187 |
| Income Tax Expense
| -0.013 | 0.12 | 0.089 | 0.048 | 0.148 | 0.041 | -0.119 | 0.061 | 0.107 | 0.088 | 0.313 | 0.168 | -0.396 | 0.019 | 0.018 |
| Net Income
| -1.59 | -2.468 | -3.397 | -1.88 | -2.488 | -3.368 | -4.266 | -3.436 | -3.559 | -3.004 | -2.335 | -0.744 | -2.004 | 0.805 | 0.555 |
| Net Income Ratio
| -0.13 | -0.243 | -0.335 | -0.213 | -0.271 | -0.388 | -0.504 | -0.428 | -0.474 | -0.426 | -0.365 | -0.129 | -0.419 | 0.209 | 0.181 |
| EPS
| -0.02 | -0.031 | -0.042 | -0.024 | -0.031 | -0.042 | -0.053 | -0.043 | -0.044 | -0.038 | -0.029 | -0.009 | -0.025 | 0.018 | 0.012 |
| EPS Diluted
| -0.02 | -0.031 | -0.042 | -0.024 | -0.031 | -0.042 | -0.053 | -0.043 | -0.044 | -0.038 | -0.029 | -0.009 | -0.025 | 0.01 | 0.007 |
| EBITDA
| 1.205 | 0.35 | -0.717 | 0.882 | 0.104 | -0.927 | -2.004 | -1.016 | -1.311 | -1.076 | -0.85 | 0.863 | -1.223 | 1.287 | 0.965 |
| EBITDA Ratio
| 0.099 | 0.034 | -0.071 | 0.1 | 0.011 | -0.107 | -0.237 | -0.127 | -0.175 | -0.152 | -0.133 | 0.15 | -0.256 | 0.334 | 0.315 |